Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
Saved in:
| Title: | Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. |
|---|---|
| Authors: | Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P |
| Source: | Pharmacology & therapeutics [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. Date of Electronic Publication: 2010 Feb 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
